Elisa Furfaro
- Infectious Diseases top 2%
- Antifungal resistance and susceptibility 22
- Epidemiology top 5%
- Fungal Infections and Studies 18
- Pneumocystis jirovecii pneumonia detection and treatment 5
- Small Animals top 10%
- Infectious Diseases and Mycology 2
-
- Neutropenia and Cancer Infections 5
-
- Complementary and Alternative Medicine Studies 2
-
- Dialysis and Renal Disease Management 2
-
- Streptococcal Infections and Treatments 2
- Co-authors
- Claudio ViscoliMałgorzata MikulskaValerio Del BonoAnna Maria RaiolaAndrea BacigalupoDaniele Roberto GiacobbeElio CastagnolaAlessandra Mularoni
- Partner nations
- ItalyUnited StatesBrazil
In The Last Decade
Elisa Furfaro
27 papers receiving 816 citations
Peers
Comparison fields: 5 of 63
- Infectious Diseases 692
- Applied Microbiology and Biotechnology 41
- Epidemiology 637
- Small Animals 49
- Critical Care and Intensive Care Medicine 30
Countries citing papers authored by Elisa Furfaro
This map shows the geographic impact of Elisa Furfaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Furfaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Furfaro more than expected).
Fields of papers citing papers by Elisa Furfaro
This network shows the impact of papers produced by Elisa Furfaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Furfaro. The network helps show where Elisa Furfaro may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elisa Furfaro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 5 | |
| 2 | 2022 | 18 | |
| 3 | 2020 | 11 | |
| 4 | 2019 | 22 | |
| 5 | 2018 | 14 | |
| 6 | 2018 | 10 | |
| 7 | 2017 | 18 | |
| 8 | 2017 | 59 | |
| 9 | 2016 | 33 | |
| 10 | 2015 | 23 | |
| 11 | 2014 | 12 | |
| 12 | 2014 | 24 | |
| 13 | 2012 | 9 | |
| 14 | 2012 | 32 | |
| 15 | 2012 | 80 | |
| 16 | 2012 | 64 | |
| 17 | 2011 | 48 | |
| 18 | 2010 | 39 | |
| 19 | 2009 | 108 | |
| 20 | 2008 | 25 |
About Elisa Furfaro
Elisa Furfaro is a scholar working on Infectious Diseases, Epidemiology and Periodontics, having authored 27 papers that have together received 824 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (22 papers), Fungal Infections and Studies (18 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers), Neutropenia and Cancer Infections (5 papers), Complementary and Alternative Medicine Studies (2 papers), Dialysis and Renal Disease Management (2 papers), Infectious Diseases and Mycology (2 papers) and Streptococcal Infections and Treatments (2 papers). The work is most often cited by research in Infectious Diseases (692 citations), Applied Microbiology and Biotechnology (41 citations) and Epidemiology (637 citations). Elisa Furfaro has collaborated with scholars based in Italy, United States and Brazil. Frequent co-authors include Claudio Viscoli, Małgorzata Mikulska, Valerio Del Bono, Anna Maria Raiola, Andrea Bacigalupo, Daniele Roberto Giacobbe, Elio Castagnola, Alessandra Mularoni, Roberto Bandettini and Maura Faraci. Their work appears in journals such as Blood, Journal of Antimicrobial Chemotherapy and Critical Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.